BPC-157 protects and repairs your gastrointestinal lining, which can benefit conditions like ulcers, leaky gut, IBS, and inflammatory bowel disease
Structural improvements in range of motion and tissue resilience become apparent from weeks three to four
confirm exact fragment MW with the product team), studied for systemic effects on actin sequestration, cell migration, and vascular development [6]
Results shown in Fig
Subcutaneous KLOW does not reach the gut surface
The titration schedule starts at 2 mg per week for 4 weeks, escalates to 4 mg for weeks 5 through 8, then to 8 mg for weeks 9 through 12, and reaches the 12 mg maintenance dose at week 13 (Jastreboff et al., NEJM 2023)